853
Views
6
CrossRef citations to date
0
Altmetric
Brief Report

Predictive role of endothelin in left ventricular remodeling of chronic kidney disease

, , , &
Pages 183-186 | Received 25 May 2017, Accepted 06 Mar 2018, Published online: 28 Mar 2018

References

  • Rizzetto F, Leal VO, Bastos LS, et al. Chronic kidney disease progression: a retrospective analysis of 3-year adherence to a low protein diet. Ren Fail. 2017;39:357–362.
  • David-Neto E, Kamada Triboni AH, Ramos F, et al. Evaluation of MDRD4, CKD-EPI, BIS-1, and modified Cockcroft–Gault equations to estimate glomerular filtration rate in the elderly renal-transplanted recipients. Clin Transplant. 2016;30:1558–1563.
  • Dsimone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adulrs: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251–1260.
  • Yao T. Physiology. 5th ed. Beijing: People’s Medical Publishing House; 2000. p. 215–216.
  • Palmieri V, Bella JN, Arnett DK, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects. Circulation. 2001;103:103–107.
  • Lin J, Wang F, Weiner RB, et al. Blood pressure and LV remodeling among American-style football players. JACC Cardiovasc Imaging. 2016;9:1367–1376.
  • Cho H, Choi HJ, Kang HG, et al. Influence of the method of definition on the prevalence of left-ventricular hypertrophy in children with chronic kidney disease: data from the know-Ped CKD study. Kidney Blood Press Res. 2017;42:406–415.
  • Bacharova L, Estes HE, Schocken DD, et al. The 4th report of the working group on ECG diagnosis of left ventricular hypertrophy. J Electrocardiol. 2017;50:11–15.
  • Vetta F, Cicconetti P, Ronzoni S, et al. Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J. 1998;19:326–331.
  • Peng T, Hu Z, Wu L, et al. Correlation between endothelial dysfunction and left ventricular remodeling in patients with chronic kidney disease. Kidney Blood Press Res. 2014;39:420–426.
  • Zavidić T, Lodeta B, Lovrinić Đ. Use of statins in patients with chronic kidney disease to prevent cardiovascular disease. Acta Med Croatica. 2016;70:301–307.
  • Rebić D, Rašić S, Valjevac A, et al. Biomarkers of cardiovascular remodeling in patients on peritoneal dialysis. Am J Nephrol. 2014;39:92–99.
  • Fox BM, Kasztan M. Endothelin receptor antagonists in sickle cell disease: a promising new therapeutic approach. Life Sci. 2016;159:15–19.
  • Barton M, Sorokin A. Endothelin and the glomerulus in chronic kidney disease. Semin Nephrol. 2015;35:156–167.
  • Woodell TB, Hughes-Austin JM, Tran TV, et al. Associations between cystatin C-based eGFR, ambulatory blood pressure parameters, and in-clinic versus ambulatory blood pressure agreement in older community-living adults. Blood Press Monit. 2016;21:87–94.